Phase II, Partial Blind, Randomized, Placebo Controlled, 5-way Cross-over Study to Evaluate the Pharmacodynamics of BDP(Beclomethasone Diproprionate)/B17MP (Beclomethasone-17-Monoproprionate) and FORMOTEROL FUMARATE (FF) Across Two Different Dose Levels of CHF 1535 NEXThaler DPI (Dry Powder Inhaler) and CHF 1535 pMDI (Pressurized Metered-dose Inhaler)in Adult COPD (Chronic Obstructive Pumonary Disease) Patients
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2017
At a glance
- Drugs Beclometasone/formoterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- Acronyms NEXThaler
- Sponsors Chiesi
- 03 Nov 2014 Status changed from recruiting to completed, as reported by ClinicalTrials.gov record.
- 24 Apr 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 09 Dec 2013 New trial record